Literature DB >> 35463736

A Case of Premenopausal Uterine Leiomyoma, Non-cirrhotic Portal Fibrosis, Hepatic Koch's, a PET Gone Astray-Morphology Antidotes a Confounding Concoction.

Kavita Gaur1, Shailaja Shukla1, Shinjini Choudhury1, Pankaj Raj1, Sharda Patra2.   

Abstract

Uterine leiomyoma with hepatic vasculopathy, specifically non-cirrhotic portal fibrosis (NCPF), has hitherto been undescribed. NCPF is characterized by elevated portal pressure sans cirrhosis and has previously not been described in association with a gynecological pathology. We report the case of a female under evaluation for a heterogeneously enhancing intrauterine mass with multiple hepatic lesions with increased uptake of fluorodeoxyglucose on positron emission analysis. Fibroscan values were increased. Histopathologic evaluations revealed a leiomyoma with liver tissue showing tubercular granulomas, thin wispy fibrotic strands, and rounded portal tracts pointed to NCPF. No evidence of malignancy was seen. Metabolic imaging may be unreliable to distinguish between benign and malignant uterine pathology and granulomatous and malignant hepatic lesions. Elastography may also be ineffective in diagnosing the etiology of liver fibrosis. Histopathological analysis hence remains essential despite noninvasive tests. Further research is required on females afflicted with NCPF to exclude a hormonal link.

Entities:  

Keywords:  Fibrosis; Leiomyoma; Liver; Positron emission tomography; Uterus

Year:  2022        PMID: 35463736      PMCID: PMC9013869          DOI: 10.30699/IJP.2022.540258.2743

Source DB:  PubMed          Journal:  Iran J Pathol        ISSN: 1735-5303


  12 in total

1.  Primary/local hepatic tuberculosis without dissemination.

Authors:  Manoj Meena; Ramakant Dixit; Lalit Prashant Meena; Jai Kumar Samaria
Journal:  BMJ Case Rep       Date:  2015-01-27

Review 2.  Noncirrhotic portal hypertension: Medical and endoscopic management.

Authors:  S K Sarin; Cyriac Abby Philips; Rajeev Khanna
Journal:  Clin Liver Dis (Hoboken)       Date:  2015-12-09

Review 3.  Estrogen Receptors and Signaling in Fibroids: Role in Pathobiology and Therapeutic Implications.

Authors:  Mostafa A Borahay; Mehmet R Asoglu; Aymara Mas; Sarah Adam; Gokhan S Kilic; Ayman Al-Hendy
Journal:  Reprod Sci       Date:  2016-11-20       Impact factor: 3.060

4.  FIBROID UTERUS AN UNUSUAL PRESENTATION: A Case Report.

Authors:  C D Chawla; M S Chaudhary; G S Joneja; Anjali Bugga
Journal:  Med J Armed Forces India       Date:  2017-06-26

Review 5.  Idiopathic portal hypertension and extrahepatic portal venous obstruction.

Authors:  Rajeev Khanna; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2018-02-20       Impact factor: 6.047

6.  Suppressive effects of estradiol on dimethylnitrosamine-induced fibrosis of the liver in rats.

Authors:  M Yasuda; I Shimizu; M Shiba; S Ito
Journal:  Hepatology       Date:  1999-03       Impact factor: 17.425

7.  Failure of hepatic adenomas (HCA) to regress after discontinuance of oral contraceptives. An association with focal nodular hyperplasia (FNH) and uterine leiomyoma.

Authors:  W H Marks; N Thompson; H Appleman
Journal:  Ann Surg       Date:  1988-08       Impact factor: 12.969

8.  Incidence and characteristics of uterine leiomyomas with FDG uptake.

Authors:  Sadahiko Nishizawa; Masayuki Inubushi; Aki Kido; Masao Miyagawa; Takeshi Inoue; Katsura Shinohara; Makoto Kajihara
Journal:  Ann Nucl Med       Date:  2008-11-28       Impact factor: 2.668

9.  18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography for Assessing Treatment Response of Pulmonary Multidrug-Resistant Tuberculosis.

Authors:  Joon Young Choi; Byung Woo Jhun; Seung Hyup Hyun; Myung Jin Chung; Won-Jung Koh
Journal:  J Clin Med       Date:  2018-12-17       Impact factor: 4.241

10.  18-Fluorodeoxyglucose positron emission tomography for tuberculosis diagnosis and management: a case series.

Authors:  Scott K Heysell; Tania A Thomas; Costi D Sifri; Patrice K Rehm; Eric R Houpt
Journal:  BMC Pulm Med       Date:  2013-03-21       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.